IMNP
Immune Pharmaceuticals Inc.
IMNP
IMNP
Delisted
IMNP was delisted on the 25th of July, 2018.
18 hedge funds and large institutions have $1.41M invested in Immune Pharmaceuticals Inc. in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$207K | |
| 2 | +$188K | |
| 3 | +$110K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$37K |
| 5 |
Goldman Sachs
New York
|
+$27.5K |
Top Sellers
| 1 | -$69K | |
| 2 | -$60.3K | |
| 3 | -$27K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$19K |
| 5 |
Bank of New York Mellon
New York
|
-$14K |